476060.KQ
Onconic Therapeutics
KOE · Healthcare · Biotechnology · KR
KRW 15,120.00
+3.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 5.55x
- P/E 2027E
- 3.06x
- P/E 2028E
- —
- P/S forward
- 10.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- 27.82x
- PEG TTM
- —
- Price / book
- 7.91x
- Price / sales
- 8.26x
- Price / cash flow
- 40.37x
Enterprise value
- Enterprise value
- KRW 616.1B
- EV / sales
- 7.50x
- EV / EBITDA
- 32.50x
- EV / EBIT
- 35.61x
- Market cap
- KRW 678.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026